PALO ALTO, Calif., Feb. 17, 2021 /PRNewswire/ — SymphonyRM today announced the addition of former Intermountain Healthcare Chief Information Officer Marc Probst to its Board of Directors. The appointment comes amidst a period of tremendous growth and opportunity for the company. Probst is a pioneer in harnessing the power of technology to improve the lives of providers and patients. His support will help SymphonyRM achieve its mission: radically transform healthcare consumer engagement to maximize health and loyalty for every patient.
“Marc’s industry expertise and track record of innovation and leadership will be invaluable additions to our Board of Directors,” said Michael Linnert, CEO of SymphonyRM. “We’re incredibly pleased to continue our partnership with him in this new capacity and know his involvement will drive tremendous value for our organization, our customers and their patient communities.”
Probst was awarded the distinction of 2019 John E. Gall Jr. CIO of the Year by the Healthcare Information and Management Systems Society (HIMSS) and the College of Healthcare Information Executives (CHIME). He is a celebrated healthcare industry veteran whose accomplishments include helping create policy framework for meaningful use in conjunction with the federal government. During his nearly 20-year tenure at Intermountain Healthcare, he led the creation of the system’s Transformation Lab, which facilitates partnerships between clinicians and technology companies.
“SymphonyRM’s AI engine ensures that every patient touchpoint is coordinated and valuable,” said Probst. “Its ability to establish personalized and meaningful 1:1 dialogue with every consumer is a critical part of driving population health and business outcomes. I look forward to watching the company flourish, now with an inside perspective in my new role.”
Probst’s appointment comes on the heels of news that Nuvance Health, a network of hospitals and healthcare professionals across New York and Connecticut, selected SymphonyRM as its enterprise marketing automation and CRM partner. Understanding that the healthcare industry is at a critical inflection point due to accelerated interest in – and implementation of – digital health efforts over the past 11 months, SymphonyRM treats individuals not as patients, but as consumers of care, eliminating data silos and enabling state-of-the-art engagement to transform provider organizations into member-centric enterprises.
About SymphonyRM
SymphonyRM is helping health systems transform how they acquire, engage, and retain patients by creating an engagement model rivaling the capabilities of world-class, consumer-centered organizations. By generating data-driven, prioritized next best actions for every consumer, prospect, and provider in a health system, SymphonyRM is helping organizations anticipate member needs and use proactive outreach to build deeper customer relationships and drive better outcomes while increasing revenue.
For more on SymphonyRM, visit: symphonyrm.com
Connect with SymphonyRM on LinkedIn: linkedin.com/company/symphonyrm
Follow @SymphonyRM on Twitter: twitter.com/symphonyrm
Like SymphonyRM on Facebook: facebook.com/symphonyrm
View original content to download multimedia:http://www.prnewswire.com/news-releases/symphonyrm-appoints-former-intermountain-healthcare-cio-marc-probst-to-its-board-of-directors-301229548.html
SOURCE SymphonyRM
Charlotte, North Carolina--(Newsfile Corp. - December 23, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE…
AUSTIN, TEXAS / ACCESSWIRE / December 23, 2024 / Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or…
Originally published in Quest Diagnostics' 2023 Corporate Responsibility ReportNORTHAMPTON, MA / ACCESSWIRE / December 23,…
Marlborough, Massachusetts--(Newsfile Corp. - December 23, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage…
WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…
WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…